X-Feed Billboard (International)

The newsboard processes news from the NASDAQ Nordic portfolio company GlobeNewswire, which provides investors with company-relevant information. This relates in particular to events that may be relevant to the listing of companies or tradable financial instruments.

GlobNewswire (formerly PrimeNewswire) specializes in public relations solutions and digital media services. This feed adds another important source of information for investors to the popular X-Billboard portfolio.

System-State: Number of processed items 38.400 Notifications successully processed since Inception
GlobeNewsWire ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
State: 22.11.2024 | 11PM
Wed, 01.05.2024       Constellation Software

TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Constellation Software Inc. (“Constellation”) (TSX: CSU) today announced that its People Transportation Division operating as Modaxo, has completed the acquisition of the Curbside Management and Public Safety Businesses from Conduent Incorporated (Nasdaq: CNDT).

Wed, 01.05.2024       Steven Madden

LONG ISLAND CITY, N.Y., May 01, 2024 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (Nasdaq: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced financial results for the first quarter ended March 31, 2024.

Wed, 01.05.2024       Man Group

Wed, 01.05.2024       Man Group

Wed, 01.05.2024       Brookfield Infrastructure

BROOKFIELD, NEWS, May 01, 2024 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the first quarter ended March 31, 2024.

Brookfield Infrastructure
Wed, 01.05.2024       Stantec

The acquisition immediately grows Stantec’s workforce in the United Kingdom by more than 30 percent, while extending and diversifying its expertise
The acquisition immediately grows Stantec’s workforce in the United Kingdom by more than 30 percent, while extending and diversifying its expertise
Wed, 01.05.2024       Universal Stainless

BRIDGEVILLE, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) today reported net sales of $77.6 million for the first quarter of 2024, which is the second highest total in company history, following its record $79.8 million reported in the 2023 fourth quarter, and 18% higher than the first quarter 2023 total of $65.9 million.

Wed, 01.05.2024       Man Group

Wed, 01.05.2024

Wed, 01.05.2024       Man Group

Wed, 01.05.2024       Man Group

Wed, 01.05.2024

Wed, 01.05.2024       Parsons

Wed, 01.05.2024       G1 Therapeutics

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
Wed, 01.05.2024       G1 Therapeutics

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
Wed, 01.05.2024       WisdomTree Europe Equity Hedged

                

WisdomTree Europe Equity Hedged
Wed, 01.05.2024       Barrick Gold

TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) is pleased to announce that its subsidiary Barrick Gold (International Holdings) Ltd. (“Barrick”) has entered into an exploration earn-in agreement with Geophysx Jamaica Ltd. (“Geophysx”) with respect to certain properties located in Jamaica (the “Agreement”).

Wed, 01.05.2024

Wed, 01.05.2024

Wed, 01.05.2024

SAN CARLOS, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will report its first quarter 2024 financial results on Thursday, May 9, 2024. Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30 p.m. ET.

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.


On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.